153 related articles for article (PubMed ID: 3218133)
1. [Effect of DL-carnitine and gamma-butyrobetaine hydroxylase inhibitor 3-(2,2,2-trimethylhydrazinium) propionate on isoproterenol-induced changes in the metabolism of the rat myocardium].
Simkhovich BZ; Meĭrena DV; Shutenko ZhV; Khagi KhB; Briede IaL
Vopr Med Khim; 1988; 34(5):30-4. PubMed ID: 3218133
[TBL] [Abstract][Full Text] [Related]
2. [Prevention of ischemic myocardial damage by reducing the intracellular free carnitine level].
Simkhovich BZ; Vitolinia RO; Stivrinia MI; Shutenko ZhV; Meĭrena DV
Kardiologiia; 1987 Jul; 27(7):85-8. PubMed ID: 3656926
[TBL] [Abstract][Full Text] [Related]
3. 3-(2,2,2-Trimethylhydrazinium)propionate (THP)--a novel gamma-butyrobetaine hydroxylase inhibitor with cardioprotective properties.
Simkhovich BZ; Shutenko ZV; Meirena DV; Khagi KB; Mezapuķe RJ; Molodchina TN; Kalviņs IJ; Lukevics E
Biochem Pharmacol; 1988 Jan; 37(2):195-202. PubMed ID: 3342076
[TBL] [Abstract][Full Text] [Related]
4. [Biochemical characteristics of the anti-ischemic action of the new structural analog of gamma-butyrobetaine 3-(2,2,2,-trimethylhydrazine)propionate].
Simkhovich BZ; Meĭrena DV; Khagi KhB; Kalvin'sh IIa; Lukevits EIa
Farmakol Toksikol; 1987; 50(2):100-4. PubMed ID: 3582624
[TBL] [Abstract][Full Text] [Related]
5. [Regulation of carnitine-dependent metabolism of fatty acids in the rat myocardium using 3-(2,2,2-trimethylhydrazinium) propionate].
Shutenko ZhV; Simkhovich BZ; Meĭrena DV; Kalvin'sh IIa; Lukevits EIa
Vopr Med Khim; 1989; 35(2):59-64. PubMed ID: 2741413
[TBL] [Abstract][Full Text] [Related]
6. [Effect of a new structural analog of gamma-butyrobetaine-- 3-(2,2,2-trimethylhydrazine)propionate (THP) on carnitine level, carnitine-dependent fatty acid oxidation and various indices of energy metabolism in the myocardium].
Simkhovich BZ; Meĭrena DV; Khagi KhB; Kalvin'sh IIa; Lukevits EIa
Vopr Med Khim; 1986; 32(4):72-6. PubMed ID: 3765501
[TBL] [Abstract][Full Text] [Related]
7. [The effect of a structural analog of gamma-butyrobetaine, mildronate, [3-2,2,2-trimethylhydrazine)propionate] on dynamic carnitine-dependent metabolism].
Shutenko ZhV; Priedena IA; Kalvin'sh IIa; Lukevits EIa
Vopr Med Khim; 1991; 37(3):24-6. PubMed ID: 1949676
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on cardiac dysfunction induced by ischemia/reperfusion in isolated rat hearts.
Hayashi Y; Tajima K; Kirimoto T; Miyake H; Matsuura N
Pharmacology; 2000 Nov; 61(4):238-43. PubMed ID: 11093075
[TBL] [Abstract][Full Text] [Related]
9. Effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on tissue carnitine and lipid levels in rats.
Hayashi Y; Muranaka Y; Kirimoto T; Asaka N; Miyake H; Matsuura N
Biol Pharm Bull; 2000 Jun; 23(6):770-3. PubMed ID: 10864034
[TBL] [Abstract][Full Text] [Related]
10. Effect of 3-(2,2,2-trimethylhydrazinium) propionate, gamma-butyrobetaine hydroxylase inhibitor, on isoproterenol-induced mitochondrial dysfunction.
Hanaki Y; Sugiyama S; Ozawa T
Res Commun Chem Pathol Pharmacol; 1989 Apr; 64(1):157-60. PubMed ID: 2546223
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of an animal model of carnitine deficiency.
Spaniol M; Brooks H; Auer L; Zimmermann A; Solioz M; Stieger B; Krähenbühl S
Eur J Biochem; 2001 Mar; 268(6):1876-87. PubMed ID: 11248709
[TBL] [Abstract][Full Text] [Related]
12. Effect of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on myocardial derangements induced by hydrogen peroxide in the isolated perfused rat heart.
Akahira M; Hara A; Abiko Y
Fundam Clin Pharmacol; 1997; 11(4):356-64. PubMed ID: 9263766
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of activities relative to fatty acid oxidation in the liver of rats depleted of L-carnitine by D-carnitine and a gamma-butyrobetaine hydroxylase inhibitor.
Tsoko M; Beauseigneur F; Gresti J; Niot I; Demarquoy J; Boichot J; Bezard J; Rochette L; Clouet P
Biochem Pharmacol; 1995 May; 49(10):1403-10. PubMed ID: 7763283
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effect of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on energy metabolism in ischemic dog hearts.
Kirimoto T; Nobori K; Asaka N; Muranaka Y; Tajima K; Miyake H
Arch Int Pharmacodyn Ther; 1996; 331(2):163-78. PubMed ID: 8937627
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction.
Hayashi Y; Kirimoto T; Asaka N; Nakano M; Tajima K; Miyake H; Matsuura N
Eur J Pharmacol; 2000 May; 395(3):217-24. PubMed ID: 10812052
[TBL] [Abstract][Full Text] [Related]
16. [The cardioprotective action of carnitine and its structural analog 3-(2,2,2-trimethylhydrazine)propionate on cardiac energy metabolism in experimental occlusion of the coronary artery in rats].
Ratunova TM; Bauman VR; Kalvin'sh IIa
Farmakol Toksikol; 1989; 52(5):24-7. PubMed ID: 2599072
[TBL] [Abstract][Full Text] [Related]
17. [The effect of mildronate on disorders of the cardiac contractile function in rats caused by an excess of free fatty acids and ischemia].
Simkhovich BZ; Briede IaL; Ozola RA; Meĭrena DV; Kalvin'sh IIa; Lukevits EIa
Farmakol Toksikol; 1990; 53(5):27-9. PubMed ID: 2253743
[TBL] [Abstract][Full Text] [Related]
18. Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction.
Liepinsh E; Vilskersts R; Loca D; Kirjanova O; Pugovichs O; Kalvinsh I; Dambrova M
J Cardiovasc Pharmacol; 2006 Dec; 48(6):314-9. PubMed ID: 17204911
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological effects of meldonium: Biochemical mechanisms and biomarkers of cardiometabolic activity.
Dambrova M; Makrecka-Kuka M; Vilskersts R; Makarova E; Kuka J; Liepinsh E
Pharmacol Res; 2016 Nov; 113(Pt B):771-780. PubMed ID: 26850121
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of the rat liver gamma-butyrobetaine hydroxylase.
Galland S; Le Borgne F; Guyonnet D; Clouet P; Demarquoy J
Mol Cell Biochem; 1998 Jan; 178(1-2):163-8. PubMed ID: 9546596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
